stockrowQIAGEN N.V.
QGEN Healthcare Diagnostics & Research
QIAGEN N.V.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 5.65% from fiscal 2024.
- Revenue
- +0.28%
- EPS
- +7.94%
- Free cash flow
- +30.5%
- Total debt
- +13.8%
Quarter to June 2026, against a year earlier
Follow QGEN
Alert me
QIAGEN N.V. (QGEN) Current ratio
QIAGEN N.V.'s current ratio at the end of the quarter to 30 June 2026 was 2.8×, down 1.0× from fiscal 2025 (3.9×). Over the past ten years it has ranged from 1.4× (fiscal 2021) to 5.1× (fiscal 2017); the current reading is higher than 91% of that period. That is above the Diagnostics & Research industry median of 2.3× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 3.9× | 107.12% |
| FY2024 | 1.9× | (5.48%) |
| FY2023 | 2.0× | (19.00%) |
| FY2022 | 2.5× | 76.70% |
| FY2021 | 1.4× | (51.03%) |
| FY2020 | 2.8× | 72.00% |
| FY2019 | 1.7× | (25.54%) |
| FY2018 | 2.2× | (56.31%) |
| FY2017 | 5.1× | 50.83% |
| FY2016 | 3.4× | (6.10%) |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Jun 2026 | 2.8× | (11.37%) |
| Mar 2026 | 3.2× | (17.48%) |
| Dec 2025 | 3.9× | 49.83% |
| Sep 2025 | 2.6× | 61.29% |
| 42 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| BLLN BillionToOne, Inc. compare | 11.2× |
| GRAL GRAIL, Inc. compare | 8.9× |
| GH Guardant Health, Inc. compare | 3.6× |
| QGEN QIAGEN N.V. | 2.8× |
| RVTY Revvity Inc. compare | 2.7× |
| RDNT RadNet, Inc. compare | 1.5× |
| CRL Charles River Laboratories International, Inc. compare | 1.4× |
| ICLR ICON PLC compare | 1.3× |
| MEDP Medpace Holdings, Inc. compare | 0.8× |
| Diagnostics & Research industry median | 2.3× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on QGEN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement